Pliant Therapeutics Inc (NAS:PLRX)
$ 13.34 -0.06 (-0.45%) Market Cap: 804.75 Mil Enterprise Value: 380.63 Mil PE Ratio: 0 PB Ratio: 1.84 GF Score: 36/100

Pliant Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 12, 2022 / 06:15PM GMT
Release Date Price: $6.87 (-3.92%)
Joey Stringer
Needham & Company, LLC - Analyst

Good afternoon, everyone. Thank you for joining the 21st Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next company, Pliant Therapeutics. And joining us today from Pliant is CEO, Bernard Coulie. (Conference Instructions)

With that, we'll get started. I'll turn it over to Bernard for some opening remarks, and then we'll start the chat.

Bernard Coulie
Pliant Therapeutics, Inc. - President & CEO

Okay. Thanks, Joey, and thanks for joining the fireside chat. So yes, I'm Bernard Coulie, CEO of Pliant Therapeutics. At Pliant, we are focused and passionate about developing novel therapeutics against fibrotic diseases, and our lead program in IPF will be reading out soon. So I'm looking forward to the conversation with Joey.

Questions & Answers

Joey Stringer
Needham & Company, LLC - Analyst

Fantastic. Bernard, to start off with, can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot